TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 118 filers reported holding TRICIDA INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $68,505 | -99.7% | 455,300 | -79.6% | 0.00% | -100.0% |
| Q3 2022 | $23,427,000 | +159.4% | 2,235,395 | +139.6% | 0.01% | +250.0% |
| Q2 2022 | $9,030,000 | +87.5% | 932,863 | +59.2% | 0.00% | – |
| Q1 2022 | $4,817,000 | -41.6% | 585,973 | -32.1% | 0.00% | – |
| Q4 2021 | $8,250,000 | +967.3% | 862,934 | +417.9% | 0.00% | – |
| Q3 2021 | $773,000 | +47.5% | 166,625 | +37.3% | 0.00% | – |
| Q2 2021 | $524,000 | -48.9% | 121,348 | -37.4% | 0.00% | – |
| Q1 2021 | $1,026,000 | -35.7% | 193,953 | -14.2% | 0.00% | – |
| Q4 2020 | $1,596,000 | +90.5% | 226,144 | +144.4% | 0.00% | – |
| Q3 2020 | $838,000 | +312.8% | 92,515 | +1153.1% | 0.00% | – |
| Q2 2020 | $203,000 | +1.5% | 7,383 | -18.7% | 0.00% | – |
| Q1 2020 | $200,000 | -38.7% | 9,082 | -14.0% | 0.00% | – |
| Q3 2019 | $326,000 | -53.0% | 10,558 | -40.0% | 0.00% | – |
| Q2 2019 | $694,000 | +85.1% | 17,592 | +40.4% | 0.00% | – |
| Q2 2018 | $375,000 | – | 12,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,974,000 | $9,159,000 | 2.13% |
| Lion Point Capital, LP | 1,826,729 | $8,476,000 | 1.59% |
| Bleichroeder LP | 1,300,000 | $6,032,000 | 0.98% |
| Orbimed Advisors | 9,614,280 | $44,610,000 | 0.49% |
| STONEHILL CAPITAL MANAGEMENT LLC | 143,072 | $664,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 475,000 | $2,204,000 | 0.30% |
| GSA CAPITAL PARTNERS LLP | 611,048 | $2,835,000 | 0.29% |
| VR Adviser, LLC | 390,707 | $1,813,000 | 0.23% |
| Ikarian Capital, LLC | 670,771 | $3,113,000 | 0.22% |
| Point72 Asset Management, L.P. | 4,889,949 | $22,689,000 | 0.10% |